thiazolidines has been researched along with Albuminuria in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (40.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (60.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aa, JY; Ding, F; Gao, HX; He, J; Sun, RB; Wang, GJ; Wang, JK; Xie, Y; Yang, N; Zeng, CH; Zhang, JW; Zhu, XD | 1 |
| Aoki, K; Ashiya, Y; Kamiko, K; Kamiyama, H; Minagawa, F; Nakajima, S; Shibata, E; Shinoda, K; Taguri, M; Terauchi, Y | 1 |
| Aoki, C; Aso, Y; Inoue, T; Sagara, M; Suzuki, K; Taguchi, I; Tanaka, S | 1 |
| Ebata, K; Haneda, M; Itagaki, I; Kamanaka, Y; Kikkawa, R; Shigeta, Y; Shimizu, K | 1 |
| Inokuchi, T; Isogai, S; Ohe, K | 1 |
2 trial(s) available for thiazolidines and Albuminuria
| Article | Year |
|---|---|
Comparison of the administration of teneligliptin every day versus every other day in Japanese patients with type 2 diabetes: a randomized non-inferior test.
Topics: Aged; Albuminuria; Asian People; Blood Pressure; Body Weight; Diabetes Mellitus, Type 2; Dipeptidyl-Peptidase IV Inhibitors; Drug Administration Schedule; Female; Glycated Hemoglobin; Humans; Lipid Metabolism; Male; Medication Adherence; Middle Aged; Patient Satisfaction; Pyrazoles; Thiazolidines; Treatment Outcome | 2015 |
Impact of teneligliptin on oxidative stress and endothelial function in type 2 diabetes patients with chronic kidney disease: a case-control study.
Topics: Aged; Aged, 80 and over; Albuminuria; Case-Control Studies; Diabetes Mellitus, Type 2; Endothelium; Female; Humans; Male; Middle Aged; Oxidative Stress; Pyrazoles; Renal Insufficiency, Chronic; Thiazolidines; Treatment Outcome | 2016 |
3 other study(ies) available for thiazolidines and Albuminuria
| Article | Year |
|---|---|
The aldose reductase inhibitor epalrestat exerts nephritic protection on diabetic nephropathy in db/db mice through metabolic modulation.
Topics: Albuminuria; Aldehyde Reductase; Animals; Diabetic Nephropathies; Enzyme Inhibitors; Fructose; Inositol; Kidney; Male; Metabolomics; Mice; Protective Agents; Rhodanine; Sorbitol; Thiazolidines | 2019 |
The effect of an aldose reductase inhibitor (Epalrestat) on diabetic nephropathy in rats.
Topics: Albuminuria; Aldehyde Reductase; Animals; Blood Glucose; Body Weight; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Enzyme-Linked Immunosorbent Assay; Glomerular Filtration Rate; Glomerular Mesangium; Kidney; Male; Organ Size; Rats; Rats, Sprague-Dawley; Renal Circulation; Rhodanine; Thiazolidines | 1994 |
Effect of an aldose reductase inhibitor on glomerular basement membrane anionic sites in streptozotocin-induced diabetic rats.
Topics: Administration, Oral; Albuminuria; Aldehyde Reductase; Animals; Anions; Basement Membrane; Blood Glucose; Blood Pressure; Cohort Studies; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Enzyme Inhibitors; Erythrocytes; Kidney Glomerulus; Male; Rats; Rats, Wistar; Rhodanine; Sorbitol; Thiazolidines; Time Factors | 1995 |